BridgeBio Pharma, Inc. 10-Q filing
Filed 2025-08-05 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-103192
- Form type
- 10-Q
- CIK
- 0001743881
- Primary document
- https://www.sec.gov/Archives/edgar/data/1743881/000095017025103192/bbio-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BridgeBio Pharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $227.2M | - | - |
| Cost Of Revenue | $6.3M | - | - |
| Operating Income | $-238.7M | - | - |
| Eps Basic | -1.84 | - | - |
| Eps Diluted | -1.84 | - | - |
| Cash And Equivalents | $749.0M | - | - |
| Total Assets | $1.1B | - | - |
| Total Liabilities | $2.9B | - | - |
| Shareholders Equity | $-1.8B | - | - |
| Operating Cash Flow | $-279.9M | - | - |
| Capital Expenditures | $594,000 | - | - |